OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bone Metastasis: Current State of Play
Anthony Turpin, Martine Duterque‐Coquillaud, Marie-Hélène Vieillard
Translational Oncology (2019) Vol. 13, Iss. 2, pp. 308-320
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Bone metastasis: mechanisms, therapies, and biomarkers
Philippe Clézardin, Rob Coleman, Margherita Puppo, et al.
Physiological Reviews (2020) Vol. 101, Iss. 3, pp. 797-855
Open Access | Times Cited: 267

Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis
Wei Zhang, Lichen Ji, Xijun Wang, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 82

The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
Francesco Bonollo, George N. Thalmann, Marianna Kruithof‐de Julio, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1887-1887
Open Access | Times Cited: 122

Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer
Jasmine S. Owen, Aled Clayton, Helen Pearson
Biomolecules (2022) Vol. 13, Iss. 1, pp. 67-67
Open Access | Times Cited: 29

Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance
Shinya Sato, Toru Hiruma, Mitsuyuki Koizumi, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2674-2688
Open Access | Times Cited: 14

Advanced nanoscale drug delivery systems for bone cancer therapy
Nazanin Amiryaghoubi, Marziyeh Fathi, Jaleh Barar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166739-166739
Closed Access | Times Cited: 14

Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review
Sumel Ashique, Md. Faiyazuddin, Obaid Afzal, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104753-104753
Closed Access | Times Cited: 13

A case of false results of osteoscintigraphy in search of bone metastases after endoprosthesis of shoulder and hip joints
Danylo Yevdoshenko, Anastasia Boretska, Anastasiia Mazur, et al.
Ukrainian Scientific Medical Youth Journal (2025) Vol. 152, Iss. 1, pp. 7-18
Open Access

Correlação das razões neutrófilo-linfócito e plaqueta-linfócito com complicações e sobrevida pós-operatórias na cirurgia para metástase óssea do esqueleto apendicular
Matheus Silva Teixeira, Ana Valéria Brunetti Rigolino, Glauco José Pauka Mello, et al.
Revista Brasileira de Ortopedia (2025) Vol. 60, Iss. 01, pp. 001-010
Open Access

The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials
Xi Cheng, Jinrong Wei, Qi Ge, et al.
Drug Delivery (2020) Vol. 28, Iss. 1, pp. 37-53
Open Access | Times Cited: 33

Emergence of Cancer-Associated Fibroblasts as an Indispensable Cellular Player in Bone Metastasis Process
Naofumi Mukaida, Di Zhang, Soichiro Sasaki
Cancers (2020) Vol. 12, Iss. 10, pp. 2896-2896
Open Access | Times Cited: 30

Site-specific Response to Nivolumab in Renal Cell Carcinoma
Takahito Negishi, Nobuki Furubayashi, Tohru Nakagawa, et al.
Anticancer Research (2021) Vol. 41, Iss. 3, pp. 1539-1545
Open Access | Times Cited: 22

Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: a population-based real-world analysis
Lingyu Han, Weixing Dai, Shaobo Mo, et al.
International Journal of Colorectal Disease (2020) Vol. 35, Iss. 8, pp. 1575-1585
Closed Access | Times Cited: 22

Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation
Soichiro Sasaki, Di Zhang, Sadahiro Iwabuchi, et al.
Cancer Science (2021) Vol. 112, Iss. 12, pp. 4883-4893
Open Access | Times Cited: 18

Bone-modifying Agents (BMAs) in Breast Cancer
Charles L. Shapiro
Clinical Breast Cancer (2021) Vol. 21, Iss. 5, pp. e618-e630
Closed Access | Times Cited: 16

Liquid biopsies in primary and secondary bone cancers
Argia Ucci, Nadia Rucci, Marco Ponzetti
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 541-59
Open Access | Times Cited: 11

Plumbagin, a Biomolecule with (Anti)Osteoclastic Properties
Sevinj Sultanli, Soni Ghumnani, Richa Ashma, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2779-2779
Open Access | Times Cited: 14

Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment
Luis O. González, Noemí Eiró, María Fraile, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4412-4412
Open Access | Times Cited: 9

The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis
Changxing Chi, Zhiyi Fan, Binbin Yang, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 10

The rise of metastatic bone disease in Ireland
Fergus J. McCabe, Dima Jadaan, Mutaz Jadaan, et al.
Clinical & Experimental Metastasis (2020) Vol. 37, Iss. 6, pp. 693-702
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top